TRS vs ZTS · P/E 122, rev $342.9M vs P/E 25, rev $2.47B
TriMas Corporation (TRS) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
TriMas Corporation (TRS) is a packaging & containers company listed on NASDAQ.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported TRS revenue for 2026-06-30 was $342.9M. Net income was $814.2M. TRS currently screens at market cap $1.53B and trailing P/E 121.8.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
TRS currently screens at market cap $1.53B and trailing P/E 121.8. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the TRS and ZTS stock pages for the full models.
Not investment advice.